Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
06/2010
06/30/2010CN101756911A Novel sodium ozagrel preparation and preparation method thereof
06/30/2010CN101756329A Preparation method of drink for softening cardio-cerebal blood vessels
06/30/2010CN101756218A Beauty fine wine and production method
06/30/2010CN101234172B Method of preparing Chinese medicine for treating qi-deficiency type metrorrhagia
06/30/2010CN101024604B Novel dihydrochalcone compound separated and purified from drgon blood and preparation method thereof
06/29/2010US7745604 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell
06/29/2010US7745488 Therapy for neutropenia as result of radiation therapy; administering colony stimulating factor
06/29/2010US7745411 Treating anemia as a result of renal failure, AIDS, cancer, organ or bone marrow transplant, chemotherapy or radiotherapy using a peptide of given sequence, comprising angiotensin analogs
06/29/2010US7744927 Methods of promoting hematopoietic and mesenchymal cell proliferation and differentiation
06/29/2010CA2636421C A method of platelet and whole blood storage
06/29/2010CA2453516C Alpha-ketoglutarates of l-carnitine and alkanoyl l-carnitine and compositions thereof
06/29/2010CA2427992C Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
06/29/2010CA2401942C Pharmaceutical compositions for buccal and pulmonary application
06/29/2010CA2382885C Rhodamine derivatives for photodynamic diagnosis and treatment
06/29/2010CA2362051C Methods and compositions for use in perfusion applications
06/24/2010WO2010071894A2 Tfpi inhibitors and methods of use
06/24/2010WO2010071190A1 Heparin affinity erythropoietin
06/24/2010WO2010071164A1 Activated blood coagulation factor x (fxa) inhibitor
06/24/2010WO2010071121A1 Method for producing diamine derivative
06/24/2010WO2010049709A3 Therapeutic compositions comprising phenolic acids for treating conditions related to inap proriate platelet aggregation
06/24/2010WO2010049705A3 Therapeutic compositions comprising flavonoids
06/24/2010US20100162418 Recombinant protein s composition
06/24/2010US20100160620 N-pyrazole a2a receptor agonists
06/24/2010US20100160392 Histone deacetylase inhibitors
06/24/2010US20100160354 Novel compounds
06/24/2010US20100160349 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
06/24/2010US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160214 Desmopressin composition
06/24/2010US20100160212 Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
06/24/2010US20100159023 Method for stabilising blood plasma components in a lyophilisate
06/24/2010US20100159017 Composition of biocompatible microparticles of alginic acid for the controlled release of active ingredients by intravenous administration
06/24/2010US20100158999 Combination of triazine derivatives and hmg-coa reductase inhibitors
06/24/2010US20100158995 Systems for delivery and release of angiotensin-(1-7)
06/24/2010US20100158990 Transdermal method and patch for corticosteroid administration
06/24/2010US20100158989 Hemostatic Agent Composition, Delivery System and Method
06/24/2010US20100158973 Therapeutic uses of cannabidiol compounds
06/24/2010US20100158918 Polypeptides and polynucleotides encoding same
06/24/2010US20100158906 Use of recombinant monoclonal antibody with specific binding activity for cell surface phosphorylated glycoprotein in diagnosis and treatment of immune, cell proliferative and inflammatory disorders
06/24/2010US20100158891 Human Coagulation Factor VII Variants
06/24/2010US20100158890 Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitors
06/24/2010US20100158861 Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus
06/24/2010US20100158814 Fibrin-Binding Peptides and Conjugates Thereof
06/24/2010US20100158813 Microbubbles as drug delivery device
06/24/2010CA2747721A1 Tfpi inhibitors and methods of use
06/24/2010CA2747427A1 Method for producing diamine derivative
06/23/2010EP2199284A1 Pharmaceutical composition for inhibiting accumulation of amyloid- beta protein
06/23/2010EP2199283A1 Prophylactic and/or therapeutic agent for anemia, comprising tetrahydroquinoline compound as active ingredient
06/23/2010EP2199275A1 Inhibitor of ischemic disorders
06/23/2010EP2198870A1 Activator for blood coagulation factor vii promoter and utilization of the same
06/23/2010EP2197551A1 Soluble guanylate cyclase activators
06/23/2010CN1910176B Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
06/23/2010CN1894275B Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
06/23/2010CN1839957B Method for extracting haw leaf general flavone material for injection using polyamide column
06/23/2010CN101748110A Desmoteplase alpha 1 mutant
06/23/2010CN101748096A Sub totipotential stem cell and preparation method and application thereof
06/23/2010CN101747430A Two peptides with oxidation resistant function - Fe-Alpha29 peptide-porphyrin iron and Beta13 peptide-porphyrin iron
06/23/2010CN101747413A Envelope glycoprotein penetrating oligopeptide or modifier/ derivative thereof with blood platelet apoptosis activity inhibiting function and application
06/23/2010CN101747408A Technology for producing polypeptide-Fe through taking animal blood as raw material
06/23/2010CN101745116A Preparation method for copper ion chelate adsorbing medium used for curing Wilson's disease)
06/23/2010CN101745112A Treatment of TNFalpha related disorders
06/23/2010CN101745103A Normal-temperature preserved albumin preparation
06/23/2010CN101745082A Traditional Chinese medicinal composition for treating haemorrhage after medical abortion and preparation method thereof
06/23/2010CN101745067A Compound garden burnet and hairyvein agrimony soup for treating dysfunctional uterine bleeding (DUB)
06/23/2010CN101745041A Chinese medicine prescription for treating nosebleed
06/23/2010CN101745040A Chinese medicament for treating hematemesis
06/23/2010CN101744981A medicine for treating thromboangitis obliterans
06/23/2010CN101744975A Method for detecting compound lightyellow sophora root injection
06/23/2010CN101744902A Medicament for treating burns, traumatic hemorrhage and ulcers and preparation method thereof
06/23/2010CN101744880A Quality control method for total salvianolic acid injection
06/23/2010CN101744863A Persimmon leaf extract preparation, preparing method thereof and application thereof
06/23/2010CN101744862A Radix Codonopsis Pilosulae oral liquid and preparation method as well as application thereof
06/23/2010CN101744818A Sinomenine and honokiol composition and anti-angiogenic drug taking sinomenine and honokiol composition as active ingredient having synergistic action
06/23/2010CN101744784A Double-layer slow-release tablet with puerarin derivatives and preparation method thereof
06/23/2010CN101744780A Clopidogrel dispersible tablet and preparation method thereof
06/23/2010CN101744775A Tranexamic acid freeze-dried powder injection and preparation method thereof
06/23/2010CN101152290B Externally used powder preparation stypticum
06/22/2010US7741452 produced by introducing amino acid mutation(s) so that no glycosylation take place at at least one glycosylation site of hepatocyte growth factor; more stable in the blood circulation
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741312 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010US7741274 Increasing hematopoiesis; treating glucosuria, hyperglycemia and diabetes; thrombocytopenia
06/22/2010US7741047 Using histone binding protein (RBAp48) as evaluative tool in identifying modulators for treatment of sjogren's syndrome
06/22/2010US7740834 Murine zcytor17 ligand polypeptides
06/22/2010CA2549672C Antineutrophilia agent using 3(2h)-pyridazinone compounds
06/22/2010CA2500575C New derivatives of 4-oxo-4,6,7,8-tetrhydro-pyrrolo[1,2-a]pyrazine-6-carbonxamides, their preparation process and the pharmaceutical compositions that contain them
06/22/2010CA2485479C New 2-(.alpha.-hydroxypentyl) benzoates, their preparations and their uses
06/22/2010CA2444489C Benzimidazolone compounds
06/22/2010CA2444198C Nociceptin analogs
06/22/2010CA2443938C Spiroindene and spiroindane compounds as opioid ligands useful for treating pain
06/22/2010CA2425696C Coated medical devices for the treatment of vascular disease
06/22/2010CA2406177C 8.beta.-hydrocarbyl-substituted estratrienes as selectively active estrogens
06/22/2010CA2401655C Cardioprotective phosphonates and malonates
06/22/2010CA2216963C Tie-2 ligands, methods of making and uses thereof
06/17/2010WO2010068710A2 Kinase inhibitor compounds
06/17/2010WO2010068663A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/17/2010WO2010066125A1 A short peptide, preparation and uses thereof
06/17/2010US20100152274 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
06/17/2010US20100152241 Inhibitors of store operated calcium release
06/17/2010US20100152211 Inhibitors of human phosphatidylinositol 3-kinase delta
1 ... 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 ... 671